Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05497518 · ClinicalTrials.gov registry record

The KidneyCARE (Community Access to Research Equity) Study

A clinical trial of Chronic Kidney Disease and Kidney Transplant, sponsored by Tufts Medical Center.

Recruiting
Registry status
50,000
Enrollment target
1
Study location

NCT05497518: Recruiting study of Chronic Kidney Disease and Kidney Transplant, sponsored by Tufts Medical Center.

NCT05497518 is a study of Chronic Kidney Disease and Kidney Transplant that is actively recruiting participants, run by Tufts Medical Center. The registered enrollment target is 50,000 participants, above the 2,712-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (1744% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05497518, a study of Chronic Kidney Disease and Kidney Transplant, is actively recruiting participants, sponsored by Tufts Medical Center.

RECRUITING
Registry status
50,000 participants
Enrollment target
1
Study location

Study Summary

For chronic kidney disease (CKD), there is a lack of unique and powerful platform for patient engagement, research studies and public health advocacy work. The National kidney Foundation (NKF) launched the first nationwide registry for people at all stages and types of CKD, including people on dialysis and kidney transplant recipients, called the KidneyCARE Study (kidneycarestudy.org). The KidneyCARE Study is a non-interventional research study which means participants will not have to take medications or do any additional tests to participate. They are simply asked to share some personal and health information, and their experiences with their disease through a secure portal. The Study also collaborates with health systems to obtain additional electronic health records (EHR) data. This unique combination of data collected will address the gap of individualized educational resources and will enhance clinical research, clinical care, and health policy decisions to be centered on the patient. The Study is all online and can be accessed any time of day at kidneycarestudy.org. Participation is voluntary and free.

Primary Outcome

Reach 10,000 enrolled participants

Interventions

  • OTHER Observational study - registry

Study Locations (1)

Pennsylvania

  • Geisinger Clinic - Danville

Trial Details

FieldValue
Enrollment Target 50,000 participants
Start Date 2021-02-25
Est. Completion 2070-02-24
Tufts Medical Center

169 total trials

What NCT05497518 shows while recruiting

NCT05497518 is an observational study that tracks outcomes without assigning an intervention. Its 50,000 participants enrollment target places it among the larger protocols in the corpus, above the 2,712-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (1744% higher).

The record links to 3 conditions, with Chronic Kidney Disease appearing as the primary indexed condition, and to 1 intervention - of which Observational study - registry is the first listed.

NCT05497518 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05497518 about?

NCT05497518 is a clinical study titled "The KidneyCARE (Community Access to Research Equity) Study". For chronic kidney disease (CKD), there is a lack of unique and powerful platform for patient engagement, research studies and public health advocacy work. The National kidney Foundation (NKF) launched the first nationwide registry for people at all stages and types of CKD, including people on dialy...

What is the current status of trial NCT05497518?

This trial is currently recruiting. The enrollment target is 50,000 participants. The study started on 2021-02-25. Estimated completion is 2070-02-24.

What conditions does trial NCT05497518 study?

This clinical trial studies the following conditions: Chronic Kidney Disease, Kidney Transplant, Dialysis.

What interventions are being tested in trial NCT05497518?

The interventions under investigation include: Observational study - registry (OTHER).

Who is sponsoring clinical trial NCT05497518?

This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05497518 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Kidney Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05497518's enrollment target sits among peer trials

50,000 2nd of 101 higher than 99 of 101 other Chronic Kidney Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Kidney Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00500123 · 50,000 participants

    The Alpha-1 Foundation's and University of Florida's Alpha-1 Coded Testing (ACT) Study

  • NCT01885299 · 50,000 participants

    RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT

  • NCT03452774 · 50,000 participants

    SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • NCT04629586 · 50,000 participants

    The T1D Exchange Registry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05497518, the US trial registry maintained by the National Library of Medicine. NCT05497518 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.